Literature DB >> 3167806

Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer.

N Yamanaka1, T Himi, Y Harabuchi, K Hoki, A Kataura.   

Abstract

Sera from 85 patients with head and neck cancer including laryngeal cancer, hypopharyngeal cancer, nasopharyngeal cancer, and maxillary cancer were assayed for immune complexes (IC) by solid-phase anti-C3 enzyme immunoassay and for squamous cell carcinoma-related (SCC) antigen by radioimmunoassay. The positive rates of IC and SCC antigen in head and neck cancer patients were 29.4% and 34.1%, respectively. Their serum levels and positive rates were found to be elevated according to the degree of advancement of the disease stage, showing their good clinical correlations. With individual patients there was no significant relationship between IC and SCC antigen.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3167806     DOI： 10.1002/1097-0142(19881101)62:9<1932::aid-cncr2820620911>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  6 in total

1.  Squamous cell carcinoma antigen levels in patients with different stages of laryngeal cancer.

Authors:  G Namyslowski; J Klimala; D Kokocinska; M Misiolek
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 2.  History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.

Authors:  Haruhiko Nakamura; Toshihide Nishimura
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

3.  Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma.

Authors:  S Goldman; C Svensson; M Brönnergård; B Glimelius; G Wallin
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

4.  Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.

Authors:  P L Cheah; C K Liam; S F Yap; L M Looi
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

5.  MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.

Authors:  Martín E Rabassa; María V Croce; Adrián Pereyra; Amada Segal-Eiras
Journal:  BMC Cancer       Date:  2006-10-25       Impact factor: 4.430

6.  Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.

Authors:  Sumitaka Hagiwara; Eiichi Sasaki; Yasuhisa Hasegawa; Hidenori Suzuki; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Masahide Takahashi; Nobuhiro Hanai
Journal:  Cancer Med       Date:  2021-02-09       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.